Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNASDAQ:EGLT
Date2/2014
Raised$50M
Post IPO Valuation

General Information

Offices

Værløse, DNK
Lejrvej 37-39
Værløse, DK-3500, DNK

People

President, CEO

Funding

TOTAL $24.3M
FUNDING TOTAL $24.3M
Series B, 5/2012
Enso Ventures
Atlas Venture
Index Ventures
Omega Funds
Sunstone Capital
$14.3M
Partial Close, 9/2013
Index Ventures
$10M

Tags

Egalet

Egalet Ltd. is a specialty pharma company focusing on pain management. Based on the Egalet technology, the company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Recent Milestones

  • Stock
    Went public with stock symbol NASDAQ:EGLT. (2/5/14)
    Posted 2/6/14 at 8:45pm
  • Check
    Egalet — Egalet targets US$69m IPO (10/17/13)
    Posted 10/17/13 at 10:56pm via eurobiotechnews.eu
  • Dollar
    Egalet received $10M in Partial Close funding. (9/13/13)
    Posted 9/15/13 at 7:00pm via finsmes.com
  • Dollar
    Egalet received $14.3M in Series B funding. (5/7/12)
    Posted 5/7/12 at 9:37pm via dowjones.com
  • Check
    Egalet added Bob Radie as President, CEO.
    Posted 5/7/12 at 9:34pm
  • Check
    Egalet added Jean-Francois Formela as Chairman.
    Posted 2/24/14 at 9:54am

Videos

Screenshots

Egalet screenshot
Above: Egalet
Uploaded: 5/8/12

Stock Price

Sources

  1. Denmark's Egalet Grabs $14.3M, New CEO For Abuse-Resistant Drugs (pevc.dowjones.com) [edit]
  2. Egalet Closes up to $20M Funding (finsmes.com) [edit]
  3. Egalet targets US$69m IPO (eurobiotechnews.eu) [edit]
Edit This Page
Last Edited 2/24/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy